FBLG
Price
$0.25
Change
+$0.01 (+4.17%)
Updated
Dec 26 closing price
Capitalization
16.56M
Intraday BUY SELL Signals
REVB
Price
$0.86
Change
-$0.01 (-1.15%)
Updated
Dec 26 closing price
Capitalization
5.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

FBLG vs REVB

Header iconFBLG vs REVB Comparison
Open Charts FBLG vs REVBBanner chart's image
FibroBiologics
Price$0.25
Change+$0.01 (+4.17%)
Volume$1.45M
Capitalization16.56M
Revelation Biosciences
Price$0.86
Change-$0.01 (-1.15%)
Volume$54.09K
Capitalization5.09M
FBLG vs REVB Comparison Chart in %
FBLG
Daily Signal:
Gain/Loss:
REVB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FBLG vs. REVB commentary
Dec 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBLG is a Buy and REVB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 29, 2025
Stock price -- (FBLG: $0.25 vs. REVB: $0.86)
Brand notoriety: FBLG and REVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBLG: 95% vs. REVB: 47%
Market capitalization -- FBLG: $16.56M vs. REVB: $5.09M
FBLG [@Biotechnology] is valued at $16.56M. REVB’s [@Biotechnology] market capitalization is $5.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBLG’s FA Score shows that 0 FA rating(s) are green whileREVB’s FA Score has 2 green FA rating(s).

  • FBLG’s FA Score: 0 green, 5 red.
  • REVB’s FA Score: 2 green, 3 red.
According to our system of comparison, REVB is a better buy in the long-term than FBLG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBLG’s TA Score shows that 2 TA indicator(s) are bullish while REVB’s TA Score has 3 bullish TA indicator(s).

  • FBLG’s TA Score: 2 bullish, 7 bearish.
  • REVB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, REVB is a better buy in the short-term than FBLG.

Price Growth

FBLG (@Biotechnology) experienced а -3.68% price change this week, while REVB (@Biotechnology) price change was -3.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBLG($16.6M) has a higher market cap than REVB($5.1M). FBLG YTD gains are higher at: -87.550 vs. REVB (-96.114). REVB has higher annual earnings (EBITDA): -8.22M vs. FBLG (-17.74M). REVB has more cash in the bank: 12.7M vs. FBLG (4.87M). REVB has less debt than FBLG: REVB (0) vs FBLG (7.11M). FBLG (0) and REVB (0) have equivalent revenues.
FBLGREVBFBLG / REVB
Capitalization16.6M5.1M326%
EBITDA-17.74M-8.22M216%
Gain YTD-87.550-96.11491%
P/E RatioN/A0.01-
Revenue00-
Total Cash4.87M12.7M38%
Total Debt7.11M0-
TECHNICAL ANALYSIS
Technical Analysis
FBLGREVB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
49%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
FBLG
Daily Signal:
Gain/Loss:
REVB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIDU124.801.44
+1.17%
Baidu
OMDA15.950.03
+0.19%
Omada Health Inc
VSCO53.81-0.46
-0.85%
Victoria's Secret & Co
SGMT5.96-0.10
-1.65%
Sagimet Biosciences
ITRM0.30-0.01
-3.95%
Iterum Therapeutics plc

FBLG and

Correlation & Price change

A.I.dvisor tells us that FBLG and ZBIO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBLG and ZBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBLG
1D Price
Change %
FBLG100%
+5.55%
ZBIO - FBLG
33%
Poorly correlated
-1.58%
CELC - FBLG
28%
Poorly correlated
-0.35%
TERN - FBLG
28%
Poorly correlated
-2.03%
PCSA - FBLG
27%
Poorly correlated
+11.68%
REVB - FBLG
27%
Poorly correlated
-1.14%
More

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-1.14%
GNPX - REVB
48%
Loosely correlated
-3.76%
TCRT - REVB
46%
Loosely correlated
-8.24%
OGEN - REVB
44%
Loosely correlated
+2.86%
TOVX - REVB
31%
Poorly correlated
-1.70%
TSHA - REVB
31%
Poorly correlated
-1.35%
More